Jordan Drumel
About Jordan Drumel
Jordan Drumel is a Regional Sales Specialist with extensive experience in molecular diagnostics and a strong background in sales and marketing. He has held various roles in the healthcare industry, including positions at Natera, Ambry Genetics, and Abbott, and has a proven track record of achieving top-tier sales results.
Current Role at BillionToOne
Jordan Drumel serves as a Regional Sales Specialist at BillionToOne, a position he has held since 2021. In this role, he focuses on driving sales initiatives and expanding market presence in Nashville. His responsibilities include developing relationships with healthcare providers and promoting the company's innovative genetic testing solutions.
Previous Experience in Molecular Diagnostics
Prior to his current role, Jordan Drumel worked at Natera as an Organ Health - Community Nephrology Specialist for seven months in 2020. He also held the position of Account Executive - Oncology & Regional Field Trainer at Ambry Genetics from 2016 to 2020. His experience in these roles contributed to his extensive expertise in molecular diagnostics, particularly in germline and somatic genetic testing.
Educational Background
Jordan Drumel studied Business Administration and Management at Marquette University for one year from 2007 to 2008. He later attended The University of Tennessee, where he earned a Bachelor of Science in Business Administration with a focus on Marketing and Logistics from 2008 to 2011. This educational foundation supports his career in sales and management.
Sales and Leadership Experience
Jordan has a documented history of achieving top-tier sales results consistently year over year. His formal leadership management training and experience as a Regional Field Sales Trainer enhance his capabilities in leading sales teams and executing strategic initiatives. He has also worked in various sales roles across different organizations, including Abbott and ADP.
Product Launch Expertise
Jordan Drumel has significant experience in launching new products, particularly in women's prenatal health. His work with quantitative cf-DNA testing platforms demonstrates his ability to introduce innovative solutions to the market. This expertise is complemented by his background in molecular diagnostics and genetic testing.